Interleukin-l (IL-1) is markedly overexpressed in Alzheimer's disease. We f
ound the IL-IA 2,2 genotype in 12.9% of 232 neuropathologicaly confirmed Al
zheimer's disease patients and 6.6% of 167 controls from four centers in th
e United Kingdom and United States (odds ratio, 3.0; controlled for age and
for ApoE (apolipoprotein El genotype). Homozygosity for both allele 2 of I
L-IA and allele 2 of IL-IB conferred even greater risk (odds ratio, 10.8).
IL-1 genotypes may confer risk for Alzheimer's disease through IL-1 overexp
ression and IL-1-driven neurodegenerative cascades.